Saturday, March 18, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Military Issues RFI for ‘Virus Like Particle’ Vaccine Production

by Global Biodefense Staff
May 29, 2012

The Chemical Biological Medical Systems Joint Vaccine Acquisition Program (CBMS-JVAP) is the organization responsible for developing, producing and stockpiling FDA-licensed vaccine systems to protect the military personnel from biological agents. The current CBMS-JVAP portfolio includes vaccines at varying stages of clinical development in addition to FDA licensed vaccines. 

CBMS-JVAP yesterday issued a Request for Information (RFI) seeking input from manufacturers with the capability to deliver a Good Manufacturing Practices (GMP) product that will be suitable for use in humans by the government to support non-clinical and Phase 1 studies under an Investigational New Drug (IND) application. Specifically, the government is seeking a manufacturer with the capability to conduct manufacturing of government owned Virus Like Particles (VLPs) vaccines. The government plans to initiate manufacturing efforts in early 2013.

Companies with the experience and the capability to develop, manufacture and produce a VLP vaccine under cGMP manufacturing conditions are invited to respond to the RFI.

Further details are available under Solicitation Number: W911QY-12-S-0018. The response deadline is June 13, 2012.

Tags: JPEO-CBRNDRFIVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC